Hospital Clínico San Carlos de Madrid -ko ikertzaileekin lankidetzan egindako argitalpenak (41)

2024

  1. CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine

    Cephalalgia : an international journal of headache, Vol. 44, Núm. 4

  2. Diagnóstico y tratamiento de los trastornos de la presión intracraneal: Documento de consenso del Grupo de Estudio de Cefaleas de la Sociedad Española de Neurología

    Neurologia

  3. Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study

    Pain Medicine (United States), Vol. 25, Núm. 3, pp. 194-202

  4. Embolic Events in Infective Endocarditis: A Comprehensive Review

    Reviews in Cardiovascular Medicine, Vol. 25, Núm. 3

  5. Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study

    European Journal of Neurology, Vol. 31, Núm. 5

2023

  1. Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 Variant

    Expert Review of Neurotherapeutics, Vol. 23, Núm. 2, pp. 179-186

  2. Study about the Manchester Triage System subtriage in patients that visited the Emergency Department due to headache

    Neurologia, Vol. 38, Núm. 4, pp. 270-277

  3. Telemedicine in the management of patients with headache: current situation and recommendations of the Spanish Society of Neurology's Headache Study Group

    Neurologia, Vol. 38, Núm. 9, pp. 635-646

2022

  1. Headache education and management in Cameroon: a healthcare provider study

    Acta Neurologica Belgica, Vol. 122, Núm. 1, pp. 75-81

  2. Machine-learning-based approach for predicting response to anti-calcitonin gene-related peptide (CGRP) receptor or ligand antibody treatment in patients with migraine: A multicenter Spanish study

    European Journal of Neurology, Vol. 29, Núm. 10, pp. 3102-3111

  3. Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients

    Cephalalgia, Vol. 42, Núm. 8, pp. 804-809

  4. Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection

    Cephalalgia, Vol. 42, Núm. 14, pp. 1521-1531

  5. The cognitive impact of guard shifts in physicians: a before-after study

    Neurological Sciences, Vol. 43, Núm. 3, pp. 1701-1708

2021

  1. 1st Post-European Headache Federation Meeting: A review of the latest developments presented at the 2020 European Headache Federation Congress

    Revista de Neurologia

  2. Eagle syndrome: Toward a clinical delimitation

    Neurologia, Vol. 36, Núm. 6, pp. 412-417

  3. Failure to monoclonal antibodies against CGRP or its receptor does not preclude lack of efficacy to other drugs from the same therapeutic class

    Neurologia

  4. Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: A meta-analysis of the current literature

    European Journal of Neurology, Vol. 28, Núm. 11, pp. 3820-3825

  5. Identifying areas for improvement in epilepsy management in developing countries: An experience of neurocooperation in Cameroon

    Neurologia, Vol. 36, Núm. 1, pp. 29-33

  6. Impact of the COVID-19 pandemic on the training of Spanish neurology residents

    Neurology Perspectives, Vol. 1, Núm. 2, pp. 124-130

  7. Management of thunderclap headache in the emergency room: A retrospective cohort study

    Cephalalgia, Vol. 41, Núm. 6, pp. 711-720